Targeted radiation boost for bulky cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests adding an extra, targeted radiation dose directly into the tumor for women with bulky cervical cancer, alongside standard chemoradiation. It aims to improve local control without increasing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have squamous cell carcinoma of the cervix (the most common type).
- Your tumor must be bulky — at least 6 cm across or 60 cubic centimeters in volume.
- You must be between 19 and 80 years old.
- You must be able to carry out daily activities with little to no help (ECOG score 0 to 2).
- You should not have had chemotherapy or radiation to the abdomen/pelvis before this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding immunotherapy to chemotherapy, then giving chemotherapy together with radiation, works better for advanced cervical cancer. It aims to improve cancer control and help people live longer, without major safety issues.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This study tests a new way to plan a type of radiation called brachytherapy for advanced cervical cancer. It uses virtual images to see if this method can treat the tumor just as well while being safer.
This trial studies whether adding controlled heat (“hyperthermia”) to radiation therapy (or radiation with chemotherapy) can improve outcomes in advanced cervical cancer. It focuses on people who can safely receive intensive pelvic radiation and heat treatment.
This trial compares two types of radiation boost therapy for locally advanced cervical cancer: a newer, precise type called SABR versus the standard brachytherapy. The goal is to see if SABR works as well or better with fewer side effects.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.